Adults hospitalized for COVID-19 receiving SNG001 versus placebo more likely to show clinical improvement
Routine COVID-19 Testing Improves Safety of Elective Surgery
Benefits of nasal swab testing seen in high-transmission areas and before major surgery
Sixty-Day Outcomes Examined for Hospitalized COVID-19 Patients
29.2 percent died during hospitalization or within 60 days of discharge; ongoing morbidity was common
India and Texas Partner to Develop COVID-19 Vaccine
A Hyderabad-based vaccine and pharmaceutical company announced the initiation of a Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India following approval from the Drugs Controller General of India.
This early-stage study’s results are expected to be available by February 2021.
OCD Symptoms Worsening Among Children During COVID-19
Worsening was most pronounced among children with early age of onset, family history of ADHD
AKI Common in U.S. Veterans Hospitalized With COVID-19
AKI associated with increased odds of mechanical ventilation use, longer hospital stay, increased risk for death
Polio Vaccinations Coming to South Sudan
A campaign aimed at vaccinating 1.5 million children against polio was recently launched in South Sudan, located in northern Africa.
Currently, 15 cases of vaccine-derived poliomyelitis are confirmed in seven counties across five states, namely Northern Bahr El Ghazal, Western Bahr El Ghazal, Warrap, Lakes, and Eastern Equatoria. The reported cases are children under five years of age who now have irreversible paralysis, announced the World Health Organization (WHO) on November 13, 2020.
Canada Expands Smallpox Vaccine Indications
A Denmark-based vaccine producer announced that Health Canada has expanded the approval of the Company’s non-replicating smallpox vaccine, IMVAMUNE® to include indications for monkeypox and related orthopoxvirus infections and disease in adults 18 years of age and older determined to be at high risk for exposure.
IMVAMUNE is currently approved in Canada under the Extraordinary Use New Drugs Pathway.
Protect Your Family From Fraudulent Flu Products
The winter flu season may soon bring out dishonest sellers marketing fraudulent products to unsuspecting consumers, who are already concerned about protecting themselves from COVID-19, said the U.S Food and Drug Administration (FDA).
These products can be found online, including popular marketplaces, and in retail stores. They may be labeled as dietary supplements, foods, hand sanitizers, nasal sprays, or devices.
Protect Your Family From Fraudulent Flu Products
The winter flu season may soon bring out dishonest sellers marketing fraudulent products to unsuspecting consumers, who are already concerned about protecting themselves from COVID-19, said the U.S Food and Drug Administration (FDA).
These products can be found online, including popular marketplaces, and in retail stores. They may be labeled as dietary supplements, foods, hand sanitizers, nasal sprays, or devices.